Covestor’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
Other funds holding PRME
Covestor's PRME Position: Q3 2026 in Review
Covestor reduced its Prime Medicine (PRME) stake by 40% in Q3 2026, cutting 42 shares and leaving 63 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2730.
Covestor first reported a position in PRME in Q1 2023 and has held it in 15 quarters since. 187 funds tracked by Wall St. Rank hold PRME as of Q3 2026.
- Covestor held 63 shares of Prime Medicine worth $0 as of Q3 2026.
- Covestor sold 42 Prime Medicine shares in Q3 2026.
- Prime Medicine made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #2730 holding.
- Covestor first reported a position in Prime Medicine in Q1 2023 and has held it in 15 quarters since.
- 187 funds tracked by Wall St. Rank held Prime Medicine as of Q3 2026.
Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.